The neuromuscular blocking properties of the antimalarial agent, bis ( (chloro-7"-quinolyl-4") amino-2'-propyl) -1,4-piperazine
Castles, T.R.; Loth, E.; Crawford, C.R.; Lee, C.C.
Journal of Pharmacology and Experimental Therapeutics 172(1): 44-51
1970
ISSN/ISBN: 0022-3565 PMID: 5416945 Document Number: 29445
Document emailed within 1 workday
Related Documents
Lettieri, G.; Brancaccio, G.; Larizza, A. 1981: Synthesis and pharmacological activity of 4-((7-chloro-quinolyl)amino)acylamides Bollettino Chimico Farmaceutico 120(5): 308-310Torchiana, M.L.; Pendleton, R.G.; Cook, P.G.; Hanson, C.A.; Clineschmidt, B.V. 1983: Apparent irreversible H2-receptor blocking and prolonged gastric antisecretory activities of 3-N-(3-[3-(1-piperidinomethyl)phenoxy]propyl) amino-4-amino-1,2,5-thiadiazole-1-oxide (L-643, 441) Journal of Pharmacology and Experimental Therapeutics 224(3): 514-519
Péter, M.; Gyéresi, A.; Fülöp, F. 2001: Liquid chromatographic enantioseparation of beta-blocking agents with (1R,2R)-1,3-diacetoxy-1-(4-nitrophenyl)-2-propyl isothiocyanate as chiral derivatizing agent Journal of Chromatography A 910(2): 247-253
Huidobro-Toro, J.P.; Carpi, A. 1976: Selective blocking properties of chloro acetyl catechol (CAC) on the alpha-adrenergic receptor Archives Internationales de Pharmacodynamie et de Therapie 222(2): 180-192
Tuba, Z.; Mahó, S. 1992: Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan) Acta Pharmaceutica Hungarica 62(3): 73-81
Parker, T.S.; Macri, J.R.; Jenden, D.J. 1976: A new neuromuscular blocking agent: 1-methyl, 1(2-hydroxyethyl) aziridinium tosylate (cyclocholine) Proceedings of the Western Pharmacology Society 19: 79-86
Varma, Y.S.; Sharma, P.L. 1971: Clinical experience with pancuronium bromide (NA97): a new steroid neuromuscular blocking agent Indian Journal of Medical Research 59(1): 69-75
Deniker, P.; Lôo, H.; Verdeaux, G.; Oughourlian, J.M. 1975: Clinical and electroencephalographic study of a new antidepressive agent, mono-methyl-amino-propyl-dibenzo-bicyclo-octadine hydrochloride (Ciba 34, 276 Ba) L'Encephale 1(3): 265-278
Neil, G.L.; Berger, A.E.; McPartland, R.P.; Grindey, G.B.; Bloch, A. 1979: Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125) Cancer Research 39(3): 852-856
Cosnier, D.; Duchene-Marullaz, P.; Grimal, J.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate Arzneimittel-Forschung 25(10): 1557-1561
Murakami, M.; Kinukawa, M.; Kanazawa, T.; Maruyama, K.; Miyagi, M.; Miyata, H.; Ujiie, A. 1996: Effects of the new class i antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity Journal of Pharmacology and Experimental Therapeutics 279(2): 877-883
Armah, B.I.; Hofferber, E.; Stenzel, W. 1988: Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone Arzneimittel-Forschung 38(9): 1287-1292
Cosnier, D.; Labrid, C.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis Arzneimittel-Forschung 25(11): 1802-1806
Brzozowski, Z.; Sławiński, J.; Angielski, S.; Szczepańska-Konkiel, M. 1985: Derivatives of 1,1-dioxo-1,4,2-benzodithiazine. III. Synthesis and diuretic properties of 3-(R,R1-phenyl)amino-6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiaz ine s Acta Poloniae Pharmaceutica 42(4): 313-318
Hara, Y.; Sato, E.; Miyagishi, A.; Aono, S.; Nakatani, H. 1979: Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 75(7): 707-720
Di Luzio, V.; Purcaro, A.; Curzi, G.; Di Segni, E.; Chiesa, R.; Di Giuseppe, F. 1972: Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity Bollettino Della Societa Italiana di Cardiologia 17(3): 179-187
Mosti, L.; Schenone, P.; Menozzi, G.; Romussi, G.; Baccichetti, F.; Carlassare, F.; Bordin, F. 1984: Synthesis and photobiological activity of N,N-disubstituted 4-amino-3-chloro-2H-thieno[2,3-h]-1-benzopyran-2-ones, 7-thioisosteres of 4-amino-3-chloroangelicins Il Farmaco; Edizione Scientifica 39(2): 81-94
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Nakanishi, M.; Tsumagari, T.; Nakanishi, A. 1971: Studies on psychotropic drugs. XI. Pharmacology of 3-chloro-5-(3-(4-piperidino-4-carbamoyl-piperidino)-propyl)-10,11-dihydro-(5H)-dibenz-(b,f)-azepine dihydrochloride monohydrate Arzneimittel-Forschung 21(3): 391-395